Macrophage migration inhibitory factor

Bibliography

• LINDE-ZWIRBLE WT, ANGUS DC, CARCILLO J, LIDICKER J, CLERMONT G, PINSKY MR: Age-specific incidence and outcome of sepsis in the US. Grit. Care Med. (1999) 27:A33.
   Web of Science ®Google Scholar
• FRANZ, DR, JAHRLING PB, FRIEDLANDER A et al.: Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 278:399–411.
   PubMed Web of Science ®Google Scholar
• JANEWAY CA, TRAVERS P, WALPORT M, SHLOMCHIK M: Innate Immunity. In: bronunobiology Garland, New York (2000:35–91.
   Google Scholar
• GEORGE M, VAUGHN JH: In vitro cell migration as a model for delayed hypersensitivity. Proc. Soc. Exp. Biol. Med. (1962) 111:514–521.
   PubMed Web of Science ®Google Scholar
• DAVID J: Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Nail. Acad. Li. USA (1966) 56:72–77.
   PubMed Web of Science ®Google Scholar
• BLOOM BR, BENNETT B: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 153:80–82.
   PubMed Web of Science ®Google Scholar
• WEISER WY, TEMPLE PA, WITEK-GIANNOTTI JS, REMOLD HG, CLARK SC, DAVID JR: Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA (1989) 86:7522–7526.
   PubMed Web of Science ®Google Scholar
• •The molecular cloning of MIF and first description of its primary structure.
   Google Scholar
• BERNHAGEN J, CALANDRA T, MITCHELL RA et al: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 365:756–759.
   PubMed Web of Science ®Google Scholar
• •The cloning of mouse MIF, its production by the pituitary gland, and its critical role in endotoxic shock.
   Google Scholar
• BERNHAGEN J, MITCHELL RA, CALANDRA T, VOELTER W, CERAMI A, BUCALA R: Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry (1994) 33:14144–14155.
   PubMed Web of Science ®Google Scholar
• WAEBER G, CALANDRA T, RODUIT R et al.: Insulin secretion is regulated by the glucose-dependent production of islet 13 cell macrophage migration inhibitory factor. Proc. Nail. Acad. Li. USA (1997) 94:4782–4787.
   PubMed Web of Science ®Google Scholar
• MEINHARDT A, BACHER M, MCFARLANE JR et al.: Macrophage migration inhibitory factor production by Leydig cells: evidence for a role in the regulation of testicular function. Endocrinology (1996) 137:5090–5095.
   PubMed Web of Science ®Google Scholar
• BACHER M, MEINHARDT A, LAN HY etal.: MIF expression in the rat brain: implications for neuronal function. Ma Med. (1998) 4:217–230.
   Google Scholar
• CALANDRA T, BERNHAGEN J, METZ CN et al: MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 377:68–71.
   PubMed Web of Science ®Google Scholar
• •The unexpected finding that MIF is released from cells by low-dose glucocorticoid stimulation, and its counter-regulatory effect on glucocorticoid inhibition of inflammatory responses.
   Google Scholar
• BOUMPAS DT, WILDER RL: Corticosteroids. In: Arthritis and Allied Conditions. Koopman WJ (Ed.), Lippincott Williams & Wilkins, Philadelphia (2000:827–847.
   Google Scholar
• BEISHUIZEN A, THUS LG, HAANEN C etal.: Macrophage migration inhibitory factor and hypothalamic-pituitary-adrenal function during critical illness. J. Gun. Endocnnol. Metab. (2001) 86:2811–2816.
   Google Scholar
• PETROVSKY N, SOCHA L, SILVA D, GROSSMAN AB, METZ C, BUCALA R: Macrophage migration inhibitory factor (MIF) exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator (2002). In Press.
   Google Scholar
• BACHER M, METZ CN, CALANDRA T etal.: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA (1996) 93:7849–7854.
   Google Scholar
• DONNELLY SC, HASLETT C, REID PT et al.: Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. (1997) 3:320–323.
   PubMed Web of Science ®Google Scholar
• DAUN JM, CANNON JG: Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IicBa. Am. J. Physiol (2000) 279:R1043–R1049.
   Google Scholar
• LEECH M, METZ C, BUCALA R, MORAND EF: Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum. (2000) 43:827–833.
   PubMed Web of Science ®Google Scholar
• WANG L, DAS H, KAMATH A, LI L, BUKOWSKI JF: Human 2V 8 2T cells augment MIF secretion and counteract the inhibitory effect of glucocorticoids on IL-113 and TNF-a production. Immunol (2002) 168:4889–4896.
   Web of Science ®Google Scholar
• BUCALA R: MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J. (1996) 10:1607–1613.
   PubMed Web of Science ®Google Scholar
• CALANDRA T, BERNHAGEN J, MITCHELL RA, BUCALA R: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. (1994) 179:1895–1902.
   PubMed Web of Science ®Google Scholar
• BOZZA M, SATOSKAR AR, LIN G et al: Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. (1999) 189:341–346.
   PubMed Web of Science ®Google Scholar
• •The first description of a MIF knockout mouse, and its endotoxin-resistant phenotype.
   Google Scholar
• ONADERA S, KANEDA K, MIZUE YKIVI, FUJINAGA M, NISHIHIRA J: Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. j Biol. Chem. (2000) 275:444–450.
   PubMed Web of Science ®Google Scholar
• ONADERA S, NISHIHIRA J, IWABUCHI K etal.: Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J. Biol. Chem. (2002) 277:7865–7874.
   Google Scholar
• MITCHELL RA, LIAO H, CHESNEY J et al.: Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Nail. Acad. Sci. USA (2002) 99:345–350.
   PubMed Web of Science ®Google Scholar
• •A mechanism of MIF's pro-inflammatory action based on inhibition of activation-induced, p53-dependent apoptosis in monocytesimacrophages.
   Google Scholar
• SAMPEY AV, HALL PH, MITCHELL RA, METZ CN, MORAND EF: Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum. (2001) 44:1273–1280.
   PubMedGoogle Scholar
• JUTTNER S, BERNHAGEN J, METZ CN, ROLLINGHOFF M, BUCALA R, GESSNER A: Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-a. P Immutiol. (1998) 161:2383–2390.
   Google Scholar
• XU D, MCSORLEY MJ, TETLEY L etal.: Protective effect on Leishmania major infection of MIF, TNF-a, and IFN-y administered orally via attenuated Salmonella typhimurium. P Immutiol. (1998) 160:1285–1289.
   Google Scholar
• SATOSKAR A, BOZZA M, RODRIGUEZ SOSA M, UN G, DAVID JR: Migration inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. (2001) 69:906–911.
   PubMed Web of Science ®Google Scholar
• MITCHELL RA, METZ CN, PENG TBR: Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). J. Biol. Chem. (1999) 274:18100–18106.
   PubMed Web of Science ®Google Scholar
• •The first identification of a signal transduction pathway for MIF, and MIF's unusual ability to induce sustained ERK-1/2 activation.
   Google Scholar
• BENIGNI F, ATSUMI T, CALANDRA T et al.: The proinflammatory mediator macrophage migration inhibitory factor (MIF) induces glucose catabolism in muscle. P Clin. Invest. (2000) 106:1291–1300.
   PubMed Web of Science ®Google Scholar
• MARSHALL CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 179–185.
   PubMedGoogle Scholar
• HOWE AK, JULIANO RL: Distinct mechanisms mediate the initial and sustained phases of integrin-mediated activation of the Raf/MEK/mitogen-activated protein kinase cascade. J. Biol. Chem. (1998) 273:27268–27274.
   PubMed Web of Science ®Google Scholar
• MURAKAMI M, NAKATANI Y, ATSUMI G, INOUE K, KUDO I: Regulatory functions of phospholipase A2. Grit. Rev Immutiol. (1997) 17:225–283.
   PubMed Web of Science ®Google Scholar
• SWANTEK JL, COBB MH, GEPPERT TD: Jun N-terminal kinase/ stress activated protein kinase (JNK/ SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor-a (TNF-a) translation: glucocorticoids inhibit TNF-a translation by blocking JNK/SAPK. Ma. Cell. Biol. (1997) 17:6274–6282.
   Web of Science ®Google Scholar
• HONMA N, KOSECKI H, AKASAKA T et al.: Deficiency of the MIF gene has no significant effect on endotoxaemia. Immunology (2000) 100:84–90.
   PubMed Web of Science ®Google Scholar
• ROGER T, DAVID J, GLAUSER MP, CALANDRA T: MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature (2001) 414:920–924.
   PubMed Web of Science ®Google Scholar
• •First description of the regulation of macrophage TLR-4 expression and innate responsiveness by MIE
   Google Scholar
• CALANDRA T, SPIEGEL LA, METZ CN, BUCALA R: Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl. Acad. Li. USA (1998) 95:11383–11388.
   PubMed Web of Science ®Google Scholar
• HUDSON JD, SHOAIBI MA, MAESTRO R, CARNERO A, HANNON GJ, BEACH DH: A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. (1999) 190:1375–1382.
   PubMed Web of Science ®Google Scholar
• •Independent discovery of MIF as a soluble regulator of p53-dependent growth control and apoptosis.
   Google Scholar
• MAHIDHARA R, BILLIAR TR: Apoptosis in sepsis. Grit. Care Med. (2000) 28:N105–N113.
   Web of Science ®Google Scholar
• ALBINA JE, CUI S, MATEO RB, REICHNER JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. Immutiol. (1993) 150:5080–5085.
   Google Scholar
• KLEEMANN R, HAUSSER A, GEIGER G et al.: Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab 1. Nature (2000) 408:211–216.
   PubMed Web of Science ®Google Scholar
• SUZUKI M, SUGIMOTO H, NAKAGAWA A, TENAKA I, NISHIHIRA J, SAKAI M: Crystal structure of the macrophage migration inhibitory factor from rat liver. Nature Struct. Biol. (1996) 3:259–266.
   PubMedGoogle Scholar
• •Crystal structure determination of MIF, revealing a novel protein fold and structural superfamily.
   Google Scholar
• SUN HW, BERNHAGEN J, BUCALA R, LOLIS E: Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc. Nati Acad. Li. USA (1996) 93:5191–5196.
   PubMed Web of Science ®Google Scholar
• •Crystal structure determination of MIF, revealing a novel protein fold and structural superfamily.
   Google Scholar
• ROSENGREN E, BUCALA R, AMAN P et al.: The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Ma. Med. (1996) 2:143–149.
   PubMed Web of Science ®Google Scholar
• •Discovery of MIF's tautomerase activity.
   Google Scholar
• SUBRAMANYA HS, ROPER DI, DAUTER Z et al.: Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry (1996) 35:792–802.
   PubMed Web of Science ®Google Scholar
• MATSUNAGA J, SINHA D, PANNELL L et al.: Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines. J. Biol. Chem. (1999) 274:3268–3271.
   PubMed Web of Science ®Google Scholar
• ROSENGREN E, AMAN P, THELIN S et al.: The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett. (1997) 417:85–88.
   PubMed Web of Science ®Google Scholar
• TAYLOR AB, JOHNSON WHJ, CZERWINSKI RM et al.: Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition. Biochemistry (1999) 38:7444–7452.
   Google Scholar
• SWOPE M, SUN HW, BLAKE PR, LOLIS E: Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J. (1998) 17:3534–3541.
   PubMed Web of Science ®Google Scholar
• STIVERS JT, ABEYGUNAWARDANA C, MILDVAN AS, HAJIPOUR G, WHITMAN CP: 4-Oxalocrotonate tautomerase: pH dependence of catalysis and pKa values of active site residues. Biochemistry (1996) 35:814–823.
   PubMed Web of Science ®Google Scholar
• BENDRAT K, AL-ABED Y, CALLAWAY DJ etal.: Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry (1997) 36:15356–15362.
   Google Scholar
• HERMANOWSKI-VOSATKA A, MUNDT SS, AYALA JM et al.: Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry (1999) 38:12841–12849.
   PubMed Web of Science ®Google Scholar
• LUBETSKY JB, SWOPE M, DEALWIS C,BLAKE P, LOLIS E: Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry (1999) 38:7346–7354.
   PubMed Web of Science ®Google Scholar
• •Description of MIF's catalytic function and the critical role of the Prol nucleophile. Expert Op/n. Ther. Targets (2003) 7(2)
   Google Scholar
• LUBETSKY JB, DIOS A, HAN J et al: The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. I Biol. Chem. (2002) 277:24976–24982.
   Web of Science ®Google Scholar
• •Exploitation of the catalytic site for the design of small-molecule MIF inhibitors.
   Google Scholar
• KLEEMANN R, KAPURNIOTU A, FRANK RW et al: Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. Mol Biol. (1998) 280:85–102.
   Web of Science ®Google Scholar
• •Discovery of a putative ceddo-reductase activity based on the MN CX X C motif.
   Google Scholar
• KLEEMANN R, MISCHKE R, KAPURNIOTU A, BRUNNER H, BERNHAGEN J: Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes. FEBS Lett. (1998) 430:191–196.
   PubMed Web of Science ®Google Scholar
• KLEEMANN R, KAPURNIOTU A, MIS CHKE R, HELD J, BERNHAGEN J: Characterization of catalytic centre mutants of macrophage migration inhibitory factor (MIF) and comparison to Cys81Ser MIF. Eur. I Biochem. (1999) 261:753–766.
   PubMedGoogle Scholar
• JUNG H, KIM T, CHAE HZ, KIM KT, HA H: Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction. j Biol. Chem. (2001) 276:15504–15510.
   PubMedGoogle Scholar
• FELDMANN M, MAINI RN: Anti-TNF-a therapy of rheumatoid arthritis: what have we learned? Ann. Rev. Immurrol (2001) 19:163–196.
   PubMed Web of Science ®Google Scholar
• BAUGH JA, BUCALA R: Mechanisms for modulating TNF-a in immune and inflammatory disease. Curr. Opin. Drug Discov. Dev. (2001) 4:635–650.
   PubMedGoogle Scholar
• VINCENT JL, MORENO R, TAKALA J: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. (1996) 22:707–710.
   PubMed Web of Science ®Google Scholar
• YOUNG LS: Sepsis Syndrome. In: Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, New York (2000):806–820.
   Google Scholar
• ABRAHAM E: Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med. (1999) 25:556–566.
   PubMed Web of Science ®Google Scholar
• CALANDRA T, ECHTENACHER B, ROY DL et al: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. (2000) 6:164–169.
   PubMed Web of Science ®Google Scholar
• •Description of MIF's critical role in sepsis, and the powerful protective effect of MIF neutralisation, even when administered several hours after infectious insult.
   Google Scholar
• SUZUKI M, SUGIMOTO H, TANAKA I, NISHIHIRA J: Substrate specificity for isomerase activity of macrophage migration inhibitory factor and its inhibition by indole derivatives. j Biochem. (1997) 122:1040–1045.
   PubMed Web of Science ®Google Scholar
• ZHANG X, BUCALA R: Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity by dopachrome analogs. Bioorg. Med. Chem. Lett. (1999) 9:3193–3198.
   PubMed Web of Science ®Google Scholar
• STAMPS SL, FITZGERALD MC, WHITMAN CP: Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry (1998) 37:10195–10202.
   PubMed Web of Science ®Google Scholar
• SENTER E AL-ABED Y, METZ CN etal.: Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc. Natl. Acad. Sri. USA (2002) 99:144–149.
   Google Scholar
• RAFFA RB, CODD EE: Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays). Life Sci. (1996) 59:37–40.
   Web of Science ®Google Scholar
• DENKINGER CM, DENKINGER M, KORT JJ, METZ C, FORSTHUBER TG: In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. I Immurrol. (2003) 170:1274–1282.
   Google Scholar
• DIOS A, MITCHELL RA, ALJABARI B etal.: Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity. I Med. Chem. (2002) 45:2410–2416.
   Google Scholar
• MIKULOWSKA A, METZ CN, BUCALA R, HOLMDAHL R: Macrophage migration inhibitory factor is involved in the pathogenesis of collagen Type II-induced arthritis in mice. j Immurrol (1997) 158:5514–5517.
   Google Scholar
• LEECH M, METZ C, SANTOS L et al:Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum. (1998) 41:910–917.
   PubMed Web of Science ®Google Scholar
• LAN HY, BACHER M, YANG N et al:The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. I Exp. Med. (1997) 185:1455–1465.
   PubMed Web of Science ®Google Scholar
• CHESNEY J, METZ C, BACHER M, PENG T, MEINHARDT A, BUCALA R: An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med. (1999) 5:181–191.
   PubMed Web of Science ®Google Scholar
• OGAWA H, NISHIHIRA J, SATO Y et al: An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine (2000) 12:309–314.
   PubMed Web of Science ®Google Scholar
• BERNHAGEN J, BACHER M, CALANDRA T et al: An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. I Exp. Med. (1996) 183:277–282.
   PubMed Web of Science ®Google Scholar
• LAN HY, MU W, YANG N etal.: De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am. Pathol. (1996) 149:1119–1127.
   Google Scholar
• BROWN FG, NIKOLIC-PATERSON DJ, METZ C, BUCALA R, ATKINS RC, LAN HY: Up-regulation of macrophage migration inhibitory factor (MIF) in acute renal allograft rejection in the rat. OM. Exp. Immurrol (1999) 118:329–336.
   PubMed Web of Science ®Google Scholar
• HOU G, VALUJSKIKH A, BAYER J, STAVITSKY AB, METZ C, HEEGER PS: In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition. Transplantation (2001) 72:1890–1897.
   PubMed Web of Science ®Google Scholar
• MEYER-SIEGLER K, HUDSON PB: Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology (1996) 48:448–452.
   PubMed Web of Science ®Google Scholar
• DE JONG YP ABADIA-MOLINA AC, SATOSKAR AR et al: Development of chronic colitis is dependent on the cytokine MIF. Nat. Immurrol (2001) 2:1061–1066.
   PubMed Web of Science ®Google Scholar
• MARTINEY JA, SHERRY B, METZ CNet al.: Macrophage migration inhibitory factor (MIF) release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malaria anemia. Infect. Immun. (2000) 68:2259–2267.
   Google Scholar
• KITAICHI N, KOTAKE S, MIZUE Y et al.: High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt–Koyanagi–Harada’s disease. Microbiol. Immunol. (2000) 44:1075–1077.
   PubMed Web of Science ®Google Scholar
• TAGUCHI C, SUGITA S, TAGAWA Y, NISHIHIRA J, MOCHIZUKI M: Macrophage migration inhibitory factor in ocular fluids of patients with uveitis. Br. J. Ophthalmol. (2001) 85:1367–1371.
   PubMed Web of Science ®Google Scholar
• LIN SG, YU XY, CHEN Y-X et al.: De novo expression of macrophage migration inhibitory in atherogenesis in rabbits. Circ. Res. (2000) 87:1202–1208.
   PubMed Web of Science ®Google Scholar
• BURGER-KENTISCHER A, GOEBEL H, SEILER R et al.: Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation (2002) 105:1561–1566.
   PubMed Web of Science ®Google Scholar